Designs, develops and manufactures precision-engineered plastic components and finished drug-delivery devices across healthcare, consumer durables and industrial segments. The healthcare business surged 139% in FY26 to INR393 crore and contributed 40% of consolidated revenue, anchored on the proprietary ShailyPen Neo spring-driven pen injector platform used in Semaglutide combination products — the firm handles full design-to-manufacture of device components for pharma partners and has secured a INR423 crore pen injector order over 4 years, holding 70% share among the top-6 Canadian filers. Consumer durables revenue stood at INR511 crore in FY26 (down 9% YoY), and industrial revenue at INR87 crore (up 41% YoY). FY26 consolidated revenue was INR991 crore, exports contributing ~68%, and machine utilisation reaching 47.6%. New vertical entry includes semiconductor trays (sole Indian manufacturing partner for a Korean customer, supplies from Q4 FY27) and consumer electronics precision components (a ~INR100 crore South India plant). A 25 million pen capacity line is ramping, with a second 25 million line due Jul-Aug 2026; pen volume targets are 36 million in FY27 and ~50 million in FY28. Materials are the largest cost at 44% of revenue, capex runs at 18% of revenue, and the board has approved an enabling resolution to raise up to INR500 crore. AR · MarketPing reader · 2026-08-02
Revenue streams, as the annual report describes them. Healthcare (40%), Consumer durables, Industrial, Semiconductor trays (new), Consumer electronics (new). Precision plastics manufacturer with healthcare pivot, capital-intensive (18% capex/revenue), exports-heavy
| ₹ crore · consolidated | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue | 568 | 607 | 644 | 787 | 991 |
| EBITDA (ex other income) | 81 | 92 | 117 | 176 | 280 |
| margin % | 14.3 | 15.1 | 18.2 | 22.4 | 28.3 |
| Owners' profit | 0 | 35 | 57 | 0 | 0 |
| EPS, as reported (₹) | 39.94 | 38.32 | 12.49 | 20.29 | 36.97 |
| ROE % · ROCE % | 9.6 · 13.0 | 8.8 · 13.0 | 12.5 · 15.9 | 17.0 · 22.1 | 23.7 · 30.4 |
| Debt / equity (x) | 0.47 | 0.46 | 0.45 | 0.34 | 0.24 |
| Cash from operations | 55 | 90 | 92 | 110 | 226 |
| Capex | (111) | (94) | (87) | (68) | (178) |
| ₹ crore | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 192 | 198 | 218 | 247 | 257 | 250 | 237 | 281 |
| Profit before tax | 27 | 32 | 40 | 55 | 66 | 50 | 52 | 66 |
| Net profit | 22 | 25 | 29 | 41 | 51 | 37 | 40 | 48 |
| EPS (₹) | 4.78 | 5.49 | 6.22 | 8.95 | 11.15 | 8.13 | 8.74 | 10.45 |
| Company | M.cap ₹ cr | P/E | P/B | EV/EBITDA | ROE % | ROCE % | Rev CAGR 5y % | EBITDA m. % |
|---|---|---|---|---|---|---|---|---|
| SHAILY ENG PLASTICS LTD ◆ | 15,077 | 85.2 | 21.04 | 52.9 | 23.7 | 28.3 | — | 29.7 |
| SAFARI IND (INDIA) LTD | 7,556 | 45.8 | 6.78 | 25.5 | 15.1 | 17.9 | 44.2 | 14.0 |
| VIP INDUSTRIES LTD | 4,276 | — | 14.77 | — | (116.8) | (59.1) | 24.6 | (1.2) |
| NILKAMAL LIMITED | 3,071 | 21.9 | 1.94 | 9.9 | 7.4 | 7.3 | 12.5 | 9.7 |
| Date · filing | Category | Importance | 1-day % | 5-day % |
|---|---|---|---|---|
| 9 Sept 2026 · Final Annual Report FY26 resubmitted after revising page photos | compliance | medium | — | — |
| 6 Sept 2026 · AGM notice published in two newspapers | compliance | minimal | — | — |
| 4 Sept 2026 · Annual Report FY26: Revenue up 25.91%, PAT up 82.5% | results | high | — | — |
| 4 Sept 2026 · 46th AGM on 28 Sept 2026; Rs 3 dividend and Rs 500 crore fund raise plan | board shareholder meetings | low | — | — |
| 4 Sept 2026 · Shaily Engineering Plastics submits BRSR for FY 2025-26 | compliance | low | — | — |
| 18 Aug 2026 · Newspaper publication of 46th AGM notice and e-voting details | compliance | minimal | — | — |
| 17 Aug 2026 · Investor group meeting scheduled for Aug 21, 2026 in Baroda | board shareholder meetings | low | — | — |
| 17 Aug 2026 · Shaily Engineering Q1 FY27: revenue up 14%, EBITDA up 18%, Healthcare now 51% of mix | investor communications | medium | — | — |
| 10 Aug 2026 · Audio recording of earnings call held on 10 August 2026 submitted | investor communications | low | — | — |
| 8 Aug 2026 · MD Amit Sanghvi re-appointed for 5 years, subject to shareholder approval | management changes | high | — | — |
| Where a broker report shows | This document shows | Why |
|---|---|---|
| A rating (BUY / ADD / REDUCE / SELL) | A state: the latest filed quarter and the measured reactions |
| BAI-KAKAJI POLYMERS LIMITED | 646 | 37.2 | — | — | — | 19.3 | — | — |
| PRIMA PLASTICS LTD. | 152 | 7.7 | 0.79 | 5.2 | 11.0 | 10.4 | 6.1 | 21.3 |
| AVRO INDIA LIMITED | 106 | 2.9 | 1.18 | 9.8 | 5.1 | 6.5 | — | 8.5 |
| NIRAJ ISPAT IND LTD | 18 | 11.8 | 1.13 | — | 10.2 | 10.8 | — | 50.0 |
| Metric | Company | Group median | Rank | Better than |
|---|---|---|---|---|
| P/E (TTM) | 85.2 | 16.9 | 8 of 8 | 0% |
| P/B | 21.0 | 1.9 | 7 of 7 | 0% |
| ROCE | 28.3 | 8.9 | 1 of 10 | 100% |
| ROE | 23.7 | 8.8 | 1 of 8 | 100% |
| Debt / Equity | 0.2 | 0.2 | 6 of 8 | 29% |
| EBITDA margin | 29.7 | 17.7 | 2 of 8 | 86% |
| Revenue growth | 13.8 | (6.8) | 2 of 9 | 88% |
| Profit growth | 16.8 | (5.5) | 3 of 8 | 71% |
| Market cap | 15077 | 646 | 1 of 9 | 100% |
| an event is a fact; a rating is an opinion that requires SEBI RA registration |
| A target price and upside | The current price and the multiples against the group | a target is a forecast; a multiple is a measurement |
| Estimate years marked E | More audited years; no estimates | MarketPing publishes no forecasts — your own model lives on the Models page |
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.
